Pink SheetGeorge Tidmarsh, a founder and CEO of multiple pharmaceutical companies in the oncology and critical care medicine spaces, has been named director of the US Food and Drug Administration’s Center for D
ScripThe new director of the US Food and Drug Administration’s Center for Drug Evaluation and Research, George Tidmarsh, brings plenty of pharmaceutical experience to the post, which could be a comfort to
ScripNearly five years after its first approval for neuromyelitis optica spectrum disorder (NMOSD) in June 2020, the US Food and Drug Administration approved Amgen’s Uplizna (inebilizumab) to treat adults
ScripWhile regulatory uncertainty in the US is mounting, Amgen does not expect significant revenue impact from new tariffs implemented under US President Donald Trump, chief financial officer Peter Griffit